| abstract |
The invention provides isolated nucleic acids molecules, designated 93870 nucleic acid molecules, which encode GPCRs. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 93870 nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a 93870 gene has been introduced or disrupted. The invention still further provides isolated 938z760 proteins, fusion proteins, antigenic peptides and anti-93870 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. |